amphetamine has been researched along with Weight Loss in 14 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Weight loss is known to alter food intake and drug self-administration, but the neural basis of this is unknown." | 5.29 | Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake. ( Creese, I; Hoebel, BG; Pothos, EN, 1995) |
| " Furthermore, the presence or absence of maternal weight loss predicted MK-801 and amphetamine stimulated locomotor abnormalities in offspring." | 3.77 | Individual differences in maternal response to immune challenge predict offspring behavior: contribution of environmental factors. ( Ahlbrand, R; Bronson, SL; Horn, PS; Kern, JR; Richtand, NM, 2011) |
| "Weight loss is known to alter food intake and drug self-administration, but the neural basis of this is unknown." | 1.29 | Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake. ( Creese, I; Hoebel, BG; Pothos, EN, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (71.43) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bronson, SL | 1 |
| Ahlbrand, R | 1 |
| Horn, PS | 1 |
| Kern, JR | 1 |
| Richtand, NM | 1 |
| EISFELDER, HW | 1 |
| BARNES, RH | 1 |
| FAZEKAS, JF | 1 |
| EHRMANTRAUT, WR | 1 |
| CAMPBELL, KD | 1 |
| NEGRON, MC | 1 |
| MUSGRAVE, PW | 1 |
| WISING, P | 1 |
| WOOLAS, KD | 1 |
| COHEN, BM | 1 |
| SCHAPIRO, MM | 1 |
| BOGRAN, N | 1 |
| FISH, CH | 1 |
| Pothos, EN | 1 |
| Creese, I | 1 |
| Hoebel, BG | 1 |
| Lin, X | 1 |
| Levitsky, DA | 1 |
| King, JM | 1 |
| Campbell, TC | 1 |
| Cabib, S | 1 |
| Orsini, C | 1 |
| Le Moal, M | 1 |
| Piazza, PV | 1 |
14 other studies available for amphetamine and Weight Loss
| Article | Year |
|---|---|
Individual differences in maternal response to immune challenge predict offspring behavior: contribution of environmental factors.
Topics: Age Factors; Amphetamine; Analysis of Variance; Animals; Animals, Newborn; Antiviral Agents; Behavio | 2011 |
Treatment of obesity, The role of the doctor, drug and diet in weight loss.
Topics: Amphetamine; Amphetamines; Diet; Humans; Obesity; Physicians; Weight Loss | 1954 |
MECHANISM of weight loss by amphetamine.
Topics: Amphetamine; Amphetamines; Body Weight; Humans; Weight Loss | 1956 |
Use of anorexigenic agent in a weight reduction clinic.
Topics: Ambulatory Care Facilities; Amphetamine; Amphetamines; Obesity; Phenobarbital; Weight Loss | 1958 |
Comparative effectiveness of phenylpropanolamine and dextro amphetamine on weight reduction.
Topics: Amphetamine; Amphetamines; Dextroamphetamine; Humans; Obesity; Phenylpropanolamine; Sympathomimetics | 1959 |
Rapid weight reduction for aircrews.
Topics: Aerospace Medicine; Amphetamine; Amphetamines; Diet, Reducing; Humans; Obesity; Weight Loss | 1962 |
[Amphetamine preparations, weight reduction and placebos. A "double-blind" investigation].
Topics: Amphetamine; Amphetamines; Double-Blind Method; Obesity; Weight Loss | 1962 |
Weight reduction with 'steladex'.
Topics: Amphetamine; Amphetamines; Obesity; Tranquilizing Agents; Weight Loss | 1962 |
The clinical importance of weight reduction in patients with exogenous obesity.
Topics: Amphetamine; Amphetamines; Feeding and Eating Disorders; Humans; Obesity; Weight Loss | 1962 |
Dietless weight loss with benzphetamine (didrex): a controlled comparison with phenmetrazine and placebo.
Topics: Amphetamine; Amphetamines; Benzphetamine; Obesity; Phenmetrazine; Weight Loss | 1960 |
Use of appetite-suppressant drugs for weight reduction without dieting.
Topics: Amphetamine; Amphetamines; Appetite; Appetite Depressants; Humans; Obesity; Weight Loss | 1962 |
Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake.
Topics: Amphetamine; Animals; Autoradiography; Dopamine; Eating; Extracellular Space; Food Deprivation; Inje | 1995 |
The promotion effect of anorectic drugs on aflatoxin B(1)-induced hepatic preneoplastic foci.
Topics: Adipose Tissue, Brown; Aflatoxin B1; Amphetamine; Animals; Appetite Depressants; Biomarkers; Body Te | 1999 |
Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Psychologic | 2000 |